EXTRAWELL PHAR 00858
0.0773.75%( -0.003 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
EXTRAWELL PHAR (00858) Major Shareholders - Stakes, Shares Held and Changes - cibo
| Shareholder | |||
|---|---|---|---|
| Mao Yumin | 25.51% | 739.92M | |
| Xie YiExecutive Director | 18.96% | 550.00M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
| Shareholder | Price | Type | Stake | ||||
|---|---|---|---|---|---|---|---|
| Mao Yumin | -350.00M | -- | Sold | 739.92M | 25.51% | ||
| United Gene International Holdings Group Limited | -350.00M | -- | Sold | 550.00M | 18.96% | ||
| JNJ Investments Ltd | -350.00M | -- | Sold | 550.00M | 18.96% | ||
| Biowindow Gene Development (Hong Kong) Limited | -350.00M | -- | Sold | 550.00M | 18.96% | ||
| United Gene Group Ltd | -350.00M | -- | Sold | 550.00M | 18.96% | ||
| Ease Gold Investments Limited | -350.00M | -- | Sold | 550.00M | 18.96% | ||
| United Gene Holdings Limited | -350.00M | -- | Sold | 550.00M | 18.96% | ||
| 黄振平 | -100.00M | -- | Sold | 9.70M | 0.33% | ||
| 黄振平 | -180.00M | -- | Sold | 109.70M | 3.78% | ||
| 仰融 | -900.00M | -- | Sold | 0 | 0.00% | ||
| Mao Yumin | +350.00M | -- | Bought | 1.09B | 37.58% | ||
| Mao Yumin | 550.00M | -- | Derivatives acquired | 739.92M | 25.51% | ||
| Starcoin Foundation | -900.00M | -- | Sold | 0 | 0.00% | ||
| United Gene International Holdings Group Limited | +350.00M | -- | Bought | 900.00M | 31.03% | ||
| JNJ Investments Ltd | +350.00M | -- | Bought | 900.00M | 31.03% | ||
| Biowindow Gene Development (Hong Kong) Limited | +350.00M | -- | Bought | 900.00M | 31.03% | ||
| United Gene Group Ltd | +350.00M | -- | Bought | 900.00M | 31.03% | ||
| Ease Gold Investments Limited | +350.00M | -- | Bought | 900.00M | 31.03% | ||
| United Gene Holdings Limited | +350.00M | -- | Bought | 900.00M | 31.03% | ||
| United Gene International Holdings Group Limited | 550.00M | -- | Derivatives acquired | 550.00M | 18.96% | ||
| JNJ Investments Ltd | 550.00M | -- | Derivatives acquired | 550.00M | 18.96% | ||
| Biowindow Gene Development (Hong Kong) Limited | 550.00M | -- | Derivatives acquired | 550.00M | 18.96% | ||
| United Gene Group Ltd | 550.00M | -- | Derivatives acquired | 550.00M | 18.96% | ||
| Ease Gold Investments Limited | 550.00M | -- | Derivatives acquired | 550.00M | 18.96% | ||
| United Gene Holdings Limited | 550.00M | -- | Derivatives acquired | 550.00M | 18.96% |
This page shows the major shareholders of EXTRAWELL PHAR (00858) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.
